- Previous Close
50.60 - Open
50.50 - Bid 50.94 x --
- Ask 50.97 x --
- Day's Range
50.44 - 51.28 - 52 Week Range
32.48 - 56.98 - Volume
754,194 - Avg. Volume
3,940,974 - Market Cap (intraday)
29.7B - Beta (5Y Monthly) 0.66
- PE Ratio (TTM)
74.87 - EPS (TTM)
0.68 - Earnings Date --
- Forward Dividend & Yield 0.19 (0.38%)
- Ex-Dividend Date Jul 24, 2024
- 1y Target Est
--
Cathay Biotech Inc., a bio-manufacturing technology company, researches, develops, produces, and sells bio-based materials in China and internationally. It offers biological long-chain diacids comprising sebacic acid and octadecanedioic acid; bio-based polyamides; and bio-based pentamethylene diamine. The products are used in various applications, including textiles, pharmaceuticals, perfumes, automobiles, electronic appliances, consumer goods, and other industries. It provides its products under the TERRYL and ECOPENT brands. Cathay Biotech Inc. was incorporated in 2000 and is headquartered in Shanghai, China.
www.cathaybiotech.comRecent News: 688065.SS
View MorePerformance Overview: 688065.SS
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688065.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688065.SS
View MoreValuation Measures
Market Cap
29.52B
Enterprise Value
26.18B
Trailing P/E
74.41
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
10.70
Price/Book (mrq)
2.59
Enterprise Value/Revenue
9.47
Enterprise Value/EBITDA
55.08
Financial Highlights
Profitability and Income Statement
Profit Margin
16.46%
Return on Assets (ttm)
--
Return on Equity (ttm)
3.27%
Revenue (ttm)
2.96B
Net Income Avi to Common (ttm)
486.73M
Diluted EPS (ttm)
0.68
Balance Sheet and Cash Flow
Total Cash (mrq)
4.64B
Total Debt/Equity (mrq)
8.66%
Levered Free Cash Flow (ttm)
--